Results 171 to 180 of about 5,449 (190)

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015

International Journal of Antimicrobial Agents, 2019
James Karlowsky, Yoshinori Yamano, Roger Echols   +2 more
exaly  

Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii

Journal of Global Antimicrobial Resistance, 2020
Giancarlo Ceccarelli, Federica Sacco, Claudio Maria Mastroianni   +2 more
exaly  

In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study)

International Journal of Antimicrobial Agents, 2019
Mark Wise, Krystyna Kaźmierczak, Yoshinori Yamano   +2 more
exaly  

Cefiderocol/colistin/tigecycline

Reactions Weekly, 2021
openaire   +1 more source

Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects

Clinical Therapeutics, 2019
Takayuki Katsube, Tsutae Den Nagata
exaly  

Cefiderocol/colistin

Reactions Weekly
openaire   +2 more sources

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016

Antimicrobial Agents and Chemotherapy, 2018
James Karlowsky, Yoshinori Yamano, Roger Echols   +2 more
exaly  

Cefiderocol Sulfate Tosylate

2021
openaire   +1 more source

Synthesis of Cefiderocol

Synfacts, 2018
openaire   +1 more source

Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis

International Journal of Antimicrobial Agents
Maddalena Giannella, Federico Pèa, Pierluigi Viale   +2 more
exaly